Shaji K Kumar|S Vincent Rajkumar - JoVE Visualize

Showing results (201-210 of 742) with videos related to

Pageof 75

Sort By:

Blood Advances|July 1, 2025

From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysisEli Muchtar, Angela Dispenzieri, Francis K Buadi, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 18, 2003

Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs. laparoscopic-assisted surgery in miceMiguel Pera, Heidi Nelson, S Vincent Rajkumar, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myelomaPrashant Kapoor, Shaji K Kumar, Angela Dispenzieri, et al.

Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011

IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM)Robert A Kyle, Angela Dispenzieri, Shaji Kumar, et al.

Metabolomics : Official Journal of the Metabolomic Society|June 1, 2025

Mass spectrometry-based lipidomics identifies select triacylglycerol species as differentially abundant in the bone marrow microenvironment of patients with multiple myeloma compared to monoclonal gammopathy of unknown significanceYogesh Chawla, Emilie I Anderson, Dragan Jevremovic, et al.

Blood|October 13, 2016

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatmentEli Muchtar, Dragan Jevremovic, Angela Dispenzieri, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2018

Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple MyelomaAnkit Kansagra, Wilson I Gonsalves, Morie A Gertz, et al.

Blood Advances|June 25, 2026

Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System InvolvementAlexander Xiao, Saurabh S Zanwar, Yi Lin, et al.

Blood|July 14, 2011

Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survivalJeremy T Larsen, Cheng E Chee, John A Lust, et al.

Clinical Lymphoma, Myeloma & Leukemia|May 4, 2020

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma PatientsAbdullah S Al Saleh, Harsh V Parmar, Alissa Visram, et al.

Pageof 75

Showing results (201-210 of 742) with videos related to

Sort By:

Pageof 75

Blood Advances|July 1, 2025

From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysisEli Muchtar, Angela Dispenzieri, Francis K Buadi, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 18, 2003

Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs. laparoscopic-assisted surgery in miceMiguel Pera, Heidi Nelson, S Vincent Rajkumar, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myelomaPrashant Kapoor, Shaji K Kumar, Angela Dispenzieri, et al.

Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011

IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM)Robert A Kyle, Angela Dispenzieri, Shaji Kumar, et al.

Metabolomics : Official Journal of the Metabolomic Society|June 1, 2025

Mass spectrometry-based lipidomics identifies select triacylglycerol species as differentially abundant in the bone marrow microenvironment of patients with multiple myeloma compared to monoclonal gammopathy of unknown significanceYogesh Chawla, Emilie I Anderson, Dragan Jevremovic, et al.

Blood|October 13, 2016

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatmentEli Muchtar, Dragan Jevremovic, Angela Dispenzieri, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2018

Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple MyelomaAnkit Kansagra, Wilson I Gonsalves, Morie A Gertz, et al.

Blood Advances|June 25, 2026

Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System InvolvementAlexander Xiao, Saurabh S Zanwar, Yi Lin, et al.

Blood|July 14, 2011

Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survivalJeremy T Larsen, Cheng E Chee, John A Lust, et al.

Clinical Lymphoma, Myeloma & Leukemia|May 4, 2020

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma PatientsAbdullah S Al Saleh, Harsh V Parmar, Alissa Visram, et al.

Pageof 75